Mulroy Michael H. insider trades

Mulroy Michael H. has filed 8 Form 4s with the SEC that we hold, all for Lineage Cell Therapeutics, Inc. (LCTX), as Director. Across all of them we count 2 purchases worth $32.6K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 40,000 shares of Lineage Cell Therapeutics, Inc. worth $22.8K, dated 2024-11-22. The first filing on our record is dated 2021-07-01 and the latest 2026-07-02.

Lineage Cell Therapeutics, Inc. (LCTX)

Director · 8 filings · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2022-03-24	P, purchase reported on Form 4	7,000	$9.8K	2022-03-25	SEC
2024-11-22	P, purchase reported on Form 4	40,000	$22.8K	2024-11-25	SEC

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1509725) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms